Suzanne Ponik

Dr. Suzanne Ponik

University of Wisconsin–Madison, Madison, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Biophysical Journal
Verified
Journal Article
Closed access
KRKristin M. Riching
Kristin M. Riching
BCBenjamin L. Cox
Benjamin L. Cox
MSMax R. Salick
Max R. Salick
CPCarolyn Pehlke
Carolyn Pehlke
ARAndrew Riching
Andrew Riching
PKPatricia J. Keely
Patricia J. Keely

5 May 2013 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
KZKun Zhang
Kun Zhang
CCCallie A. Corsa
Callie A. Corsa
SPSuzanne Ponik
Suzanne Ponik
JPJulie L. Prior
Julie L. Prior
DPDavid Piwnica-Worms
David Piwnica-Worms
GLGregory D. Longmore
Gregory D. Longmore

15 October 2019 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YMYasuyuki Mizutani
Yasuyuki Mizutani
HKHiroki Kobayashi
Hiroki Kobayashi
TITadashi Iida
Tadashi Iida
NANaoya Asai
Naoya Asai
AMAtsushi Masamune
Atsushi Masamune
Masahide TakahashiMasahide Takahashi
Masahide Takahashi
Cancer-associated fibroblasts (CAF) constitute a major component of the tumor microenvironment. Recent observations in genetically engineered mouse models and clinical studies have suggested that there may exist at least two functionally different populations of CAFs, that is, cancer-promoting CAFs (pCAF) and cancer-restraining CAFs (rCAF). Although various pCAF markers have been identified, the identity of rCAFs remains unknown because of the lack of rCAF-specific marker(s). In this study, we found that Meflin, a glycosylphosphatidylinositol-anchored protein that is a marker of mesenchymal stromal/stem cells and maintains their undifferentiated state, is expressed by pancreatic stellate cells that are a source of CAFs in pancreatic ductal adenocarcinoma (PDAC). In situ hybridization analysis of 71 human PDAC tissues revealed that the infiltration of Meflin-positive CAFs correlated with favorable patient outcome. Consistent herewith, Meflin deficiency led to significant tumor progression with poorly differentiated histology in a PDAC mouse model. Similarly, genetic ablation of Meflin-positive CAFs resulted in poor differentiation of tumors in a syngeneic transplantation model. Conversely, delivery of a Meflin-expressing lentivirus into the tumor stroma or overexpression of Meflin in CAFs suppressed the growth of xenograft tumors. Lineage tracing revealed that Meflin-positive cells gave rise to α-smooth muscle actin-positive CAFs that are positive or negative for Meflin, suggesting a mechanism for generating CAF heterogeneity. Meflin deficiency or low expression resulted in straightened stromal collagen fibers, which represent a signature for aggressive tumors, in mouse or human PDAC tissues, respectively. Together, the data suggest that Meflin is a marker of rCAFs that suppress PDAC progression. Significance: Meflin marks and functionally contributes to a subset of cancer-associated fibroblasts that exert antitumoral effects.

29 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BSBong Hwan Sung
Bong Hwan Sung
ALAriana von Lersner
Ariana von Lersner
JGJorge Guerrero
Jorge Guerrero
EKEvan S. Krystofiak
Evan S. Krystofiak
DIDavid Inman
David Inman
AWAlissa M. Weaver
Alissa M. Weaver
Small extracellular vesicles called exosomes affect multiple autocrine and paracrine cellular phenotypes. Understanding the function of exosomes requires a variety of tools, including live imaging. Our previous live-cell reporter, pHluorin-CD63, allows dynamic subcellular monitoring of exosome secretion in migrating and spreading cells. However, dim fluorescence and the inability to make stably-expressing cell lines limit its use. We incorporated a stabilizing mutation in the pHluorin moiety, M153R, which now exhibits higher, stable expression in cells and superior monitoring of exosome secretion. Using this improved construct, we visualize secreted exosomes in 3D culture and in vivo and identify a role for exosomes in promoting leader–follower behavior in 2D and 3D migration. Incorporating an additional non-pH-sensitive red fluorescent tag allows visualization of the exosome lifecycle, including multivesicular body (MVB) trafficking, MVB fusion, exosome uptake and endosome acidification. This reporter will be a useful tool for understanding both autocrine and paracrine roles of exosomes.

1 March 2018 in The American Journal of Pathology
Verified
Journal Article
Closed access
KEKarla Esbona
Karla Esbona
YYYanyao Yi
Yanyao Yi
SSSandeep Saha
Sandeep Saha
MYMenggang Yu
Menggang Yu
RDRachel R. Van Doorn
Rachel R. Van Doorn
PKPatricia J. Keely
Patricia J. Keely

1 November 2016 in EBioMedicine
Verified
Journal Article
Open access
BMBrett A. Morris
Brett A. Morris
BBBrian Burkel
Brian Burkel
SPSuzanne Ponik
Suzanne Ponik
JFJing Fan
Jing Fan
JCJohn S. Condeelis
John S. Condeelis
PKPatricia J. Keely
Patricia J. Keely
Increased breast density attributed to collagen I deposition is associated with a 4-6 fold increased risk of developing breast cancer. Here, we assessed cellular metabolic reprogramming of mammary carcinoma cells in response to increased collagen matrix density using an in vitro 3D model. Our initial observations demonstrated changes in functional metabolism in both normal mammary epithelial cells and mammary carcinoma cells in response to changes in matrix density. Further, mammary carcinoma cells grown in high density collagen matrices displayed decreased oxygen consumption and glucose metabolism via the tricarboxylic acid (TCA) cycle compared to cells cultured in low density matrices. Despite decreased glucose entry into the TCA cycle, levels of glucose uptake, cell viability, and ROS were not different between high and low density matrices. Interestingly, under high density conditions the contribution of glutamine as a fuel source to drive the TCA cycle was significantly enhanced. These alterations in functional metabolism mirrored significant changes in the expression of metabolic genes involved in glycolysis, oxidative phosphorylation, and the serine synthesis pathway. This study highlights the broad importance of the collagen microenvironment to cellular expression profiles, and shows that changes in density of the collagen microenvironment can modulate metabolic shifts of cancer cells.